SCHEMBL456230

SCHEMBL456230

CCCCCC([CH]O)CCC

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
OPRM1 P35372 1/20 0.39
FDPS P14324 4/20 0.38
MAPT P10636 2/20 0.38
TRPA1 O75762 1/20 0.38
DDAH1 O94760 1/20 0.38
GAPDH P04406 1/20 0.38
GPR84 Q9NQS5 3/20 0.37
CA1 P00915 2/20 0.37
SPHK1 Q9NYA1 1/20 0.37
FFAR1 O14842 1/20 0.37
TP53 P04637 1/20 0.35
LAP3 P28838 1/20 0.35
LCK P06239 1/20 0.35
PPARD Q03181 1/20 0.35
ZDHHC20 Q5W0Z9 1/20 0.35
ZDHHC2 Q9UIJ5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8003241 0.92 LMNA (0.48) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL9098296 0.92 LMNA (0.48) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL2453298 0.92 LMNA (0.48) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL17102127 0.92 LMNA (0.48) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL5154296 0.87
SCHEMBL7765567 0.83 TSHR (0.48) LMNATSHRSMN1; SMN2FDPSMAPT
SCHEMBL4271923 0.79 TSHR (0.42) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL4281282 0.79 TSHR (0.42) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL4274455 0.79 TSHR (0.42) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL4275900 0.77 LMNA (0.42) LMNATSHRSMN1; SMN2OPRM1FDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630049-A1 MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II Henkel AG & Co. KGaA (DE) 2020-04-08 EP disclosed
US-20200093714-A1 MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II HENKEL AG & CO. KGAA (DE) 2020-03-26 US disclosed
EP-2433617-B1 Cosmetic composition containing microcapsules HENKEL AG & CO KGAA (DE) 2019-05-15 EP disclosed
WO-2018215354-A1 MICROCAPSULE SYSTEM FOR POLYSENSORY OLFACTORY EFFECTS II HENKEL AG & CO. KGAA (DE) 2018-11-29 WO disclosed
EP-2756066-B1 AGENT CONTAINING MICROCAPSULES HENKEL AG & CO KGAA (DE) 2018-11-14 EP disclosed
EP-2544812-B1 IMPROVED MICROCAPSULES AND PRODUCTION THEREOF FOLLMANN GMBH & CO KG (DE) 2018-10-24 EP disclosed
EP-2614134-B1 MICROCAPSULE CONTAINING DETERGENT OR CLEANING AGENT HENKEL AG & CO KGAA (DE) 2017-11-08 EP disclosed
US-20170020794-A1 AGENT CONTAINING MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2017-01-26 US disclosed
CN-102438740-B The microcapsules improved and preparation thereof FOLLMANN & CO. GESELLSCHAFT FuR CHEMIE-WERKSTOFFE UND -VERFAHRENSTECHNIK MBH & CO. KG (DE) 2016-03-16 CN disclosed
US-9056948-B2 Microcapsules and production thereof FOLLMANN & CO. GESELLSCHAFT FUER CHEMIE-WERKSTOFFE UND VERFAHRENSTECHNIK MBH & CO. KG (DE) 2015-06-16 US disclosed
WO-2013037575-A1 AGENT CONTAINING MICROCAPSULES HENKEL AG & CO. KGAA (DE) 2013-03-21 WO disclosed
EP-2544812-A2 IMPROVED MICROCAPSULES AND PRODUCTION THEREOF Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) 2013-01-16 EP disclosed
US-20120122694-A1 VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF Follmann & Co. Gesellschaft fur Chemie-Werkstoffe und Verfahrenstechnik mbH & Co. KG (DE) 2012-05-17 US disclosed
CN-102438740-A Improved microcapsules and their preparation FOLLMANN & CO GES FUER CHEMIE 2012-05-02 CN disclosed
EP-2433617-A2 Cosmetic composition containing microcapsules Henkel AG & Co. KGaA (DE) 2012-03-28 EP disclosed
WO-2012032145-A1 MICROCAPSULE CONTAINING DETERGENT OR CLEANING AGENT HENKEL AG & CO. KGAA (DE) 2012-03-15 WO disclosed
EP-2406002-A2 IMPROVED MICROCAPSULES, AND PRODUCTION THEREOF Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) 2012-01-18 EP disclosed
WO-2011110368-A2 IMPROVED MICROCAPSULES AND PRODUCTION THEREOF FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND -VERFAHRENSTECHNIK MBH & CO. KG (DE) 2011-09-15 WO disclosed
EP-2364773-A1 Improved microcapsules and their manufacture Follmann & Co. Gesellschaft für Chemie-Werkstoffe und -Verfahrenstechnik mbH & Co. KG (DE) 2011-09-14 EP disclosed
WO-2010102830-A2 IMPROVED MICROCAPSULES, AND PRODUCTION THEREOF FOLLMANN & CO. GESELLSCHAFT FÜR CHEMIE-WERKSTOFFE UND VERFAHRENSTECHNIK MBH & CO. KG (DE) 2010-09-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122694-A1 VERBESSERTE MICROKAPSELN UND IHRE HERSTELLUNG IMPROVED MICROCAPSULES, AND THEIR PRODUCTION THEREOF VIM, ADH5, DCXR LMNA 2569/4885TSHR 3985/4885SMN1; SMN2 3032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.